// App-Quantinova.ai

PB0917 : The Ottawa Score did not predict recurrent venous thromboembolism in the prospective TROPIQUE cohort study

Researchers

Presenter

  • C. Frere

Principal Investigators

  • P. Debourdeau

  • N. Falvo

  • Y. Benhamou

  • M. Sevestre

  • D. Farge

Medical Centers

  • Sorbonne Universite Paris Île-de-France France

  • Institut Sainte-Catherine, Avignon, Provence-Alpes-Cote d'Azur, France

  • LEO Pharma, Voisins-le-Bretonneux, Ile-de-France, France

  • Assistance Publique - Hopitaux de Paris Paris Île-de-France France

  • CHU de Dijon-Bourgogne, Dijon, Bourgogne, France

  • CHU Charles-Nicolle, Rouen, Nord-Pas-de-Calais, France

  • CHU Picardie, Amiens, Nord-Pas-de-Calais, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Breast cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved